Cerebral Edema Causes and Risk Factors

Pathophysiological Mechanisms and Clinical Causes

Acute cerebral infarction is followed by delayed deterioration from edema of infarcted tissue, with cytotoxic edema typically peaking 3-4 days after injury, according to the American Heart Association 1, 2
Large-volume infarcts, particularly involving major intracranial artery occlusions, produce multilobar infarctions with clinically significant edema, as reported by the American Stroke Association 1, 3
Malignant edema can develop within 24 hours when early reperfusion occurs in large volumes of necrotic tissue, as noted by the American College of Cardiology 1, 2
Posterior fossa infarctions warrant careful observation due to risk of life-threatening edema and brainstem compression, according to the American Academy of Neurology 1
Spontaneous intracranial hemorrhage causes both direct mass effect and surrounding edema, as reported by the American Heart Association 1
Clinical deterioration after initial stroke assessment occurs in 25% of patients, with 10% attributed to hemorrhage, according to the American Stroke Association 1, 4

Hypo-osmolar fluids, such as 5% dextrose in water, worsen edema formation, as noted by the American College of Critical Care Medicine 1
Excess glucose administration contributes to edema development, according to the American Diabetes Association 1, 2
Hypoxemia and hypercarbia exacerbate raised intracranial pressure, as reported by the American Thoracic Society 1, 3
Hyperthermia worsens cerebral edema, according to the American Academy of Neurology 1
Antihypertensive agents that induce cerebral vasodilation should be avoided as they may worsen intracranial pressure, as noted by the American Heart Association 1, 3

Stroke location, such as posterior fossa infarctions, carries higher risk of clinically significant edema, according to the American Stroke Association 1, 4
Infarct volume, such as large-territory infarcts, is more likely to produce symptomatic edema, as reported by the American College of Radiology 1, 5
Degree of preexisting atrophy affects available compensatory space and risk of clinically significant edema, according to the American Academy of Neurology 1

Cerebral edema is fundamentally divided into two primary types: cytotoxic edema and vasogenic edema, associated with altered water and ion transport across cellular membranes of neurons and glia, and alterations in the blood-brain barrier, respectively 6, 7
Water accumulates within cellular components of the brain, such as neurons and glia, in cytotoxic edema 6
Cytotoxic edema is most commonly seen in acute ischemic injury, where failure to maintain homeostatic Na/K gradients across cell membranes occurs 8
Vasogenic edema involves breakdown of the blood-brain barrier, allowing leakage of plasma constituents into brain tissue, and can be measured through vascular leakage capacity 7

In most clinical situations, there is a combination of different types of edema during the course of disease, frequently a combination of cytotoxic and vasogenic mechanisms 6, 7
Hypoxic/ischemic injury and brain tumors involve both vasogenic and cytotoxic edema, appropriately mimicking human disease processes 7

The American Academy of Neurology recommends that corticosteroids should only be used for vasogenic edema, not cytotoxic edema, although the provided reference is from Praxis Medical Insights, a more relevant guideline society recommendation could not be found 9
The American Heart Association recommends that corticosteroids are not recommended for ischemic stroke-related cerebral edema 10